Laboratory models and their role in assessing teratogenesis

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 157, Issue 3, 2011, Pages 183-187

  Daston, George P ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Biological plausibility; Developmental toxicology; Laboratory models

Indexed keywords

INDUSTRIAL CHEMICAL; PESTICIDE;

ARTICLE; DEVELOPMENTAL DISORDER; EXPERIMENTAL MODEL; EXPERIMENTAL RABBIT; EXPERIMENTAL RAT; NONHUMAN; PRIORITY JOURNAL; TERATOGENESIS;

ANIMALS; DEVELOPMENTAL DISABILITIES; HUMANS; MODELS, ANIMAL; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; TERATOGENS; TOXICITY TESTS;

ANIMALIA;

EID: 79960554254     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30312     Document Type: Article

References (23)

1. Antebi A. Nuclear hormone receptors in C. elegans (January 03, 2006), WormBook, ed. The C. elegans Research Community, WormBook, doi/10.1895/wormbook.1.64.1.
2. Carney EW, Tornesi B, Keller C, Findlay HA, Nowland WS, Marshall VA, Ozolins TRS. 2007. Refinement of a morphological scoring system for postimplantation rabbit conceptuses. Birth Defects Res B 80: 213-222.
3. Carney EW, Tornesi B, Markham DA, Rasoulpour RJ, Moore N. 2008. Species-specificity of ethylene glycol-induced developmental toxicity: Toxicokinetic and whole embryo culture studies in the rabbit. Birth Defects Res B Dev Reprod Toxicol 83: 573-581.
4. Chapin R, Augustine-Rauch K, Beyer B, Daston G, Finnell R, Flynn T, Hunter S, Mirkes P, O'Shea KS, Piersma A, Sandler D, Vanparys P, vanMaele-Fabry G. 2008. State of the art in developmental toxicity screening methods and a way forward: A meeting report addressing embryonic stem cells, whole embryo culture and zebrafish. Birth Defects Res B Dev Reprod Toxicol 83: 446-456.
5. Chernoff N, Rogers JM. 2004. Supernumerary ribs in developmental toxicity bioassays and in human populations: Incidence and biological significance. J Toxicol Environ Health B Crit Rev 7: 437-449.
6. Daston GP, Knudsen TB. 2010. Fundamental concepts, current regulatory design and interpretation. In: Knudsen TB, Daston GP, editors. Comprehensive toxicology, vol. 12, developmental toxicology. Kidlington, UK: Elsevier. pp 3-9.
7. Daston GP, Naciff JM. 2010. Predicting developmental toxicity through toxicogenomics. Birth Defects Res C Embryo Today 90: 110-117.
8. Glazier JA, Zhang Y, Swat M, Zaitlen B, Schnell S. 2008. Coordinated action of N-CAM, N-cadherin, EphA4, and ephrinB2 translates genetic prepatterns into structure during somitogenesis in chick. Curr Top Dev Biol 81: 205-247.
9. Greenberg AJ, Stockwell SR, Clark AG. 2008. Evolutionary constraint and adaptation in the metabolic network of Drosophila Mol Biol Evol 25: 2537-2546.
10. Hurtt ME, Cappon GD, Browning A. 2003. Proposal for a tiered approach to developmental toxicity testing for veterinary pharmaceutical products for food-producing animals. Food Chem Toxicol 41: 611-619.
11. Janer G, Slob W, Hakkert BC, Vermiere T, Piersma AH. 2008. A retrospective analysis of developmental toxicity studies in rat and rabbit: What is the added value of the rabbit as an additional test species? Regul Toxicol Pharmacol 50: 206-217.
12. Knudsen TB, Houck KA, Sipes NS, Singh AV, Judson RS, Martin MT, Weissman A, Kleinstreuer NC, Mortensen HM, Reif DM, Rabinowitz JR, Setzer RW, Richard AM, Dix DJ, Kavlock RJ. 2011. Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets. Toxicology 282: 1-15.
13. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr, Lott IT, et al. 1985. Retinoic acid embryopathy. N Engl J Med 313: 837-841.
14. Middaugh LD, Dow-Edwards D, Li AA, Sandler JD, Seed J, Sheets LP, Shuey DL, Slikker W Jr, Weisenburger WP, Wise LD, Selwyn MR. 2003. Neurobehavioral assessment: A survey of use and value in safety assessment studies. Toxicol Sci 76: 250-261 [Epub 2003 Aug 12].
15. NCTR (National Center for Toxicological Research). 1984. Reliability of experimental studies for predicting hazards to human development. Final Report for Experiment 6015.
16. Newman LM, Johnson EM, Staples RE. 1993. Assessment of the effectiveness of animal developmental toxicity testing for human safety. Reprod Toxicol 7: 359-390.
17. National Research Council Committee on Developmental Toxicology. 2000. Scientific Frontiers in developmental toxicology and risk assessment. Washington, DC: National Academy Press.
18. Rogers JM, Chernoff N, Keen CL, Daston GP. 2005. Evaluation and interpretation of maternal toxicity in Segment II studies: Issues, some answers, and data needs. Toxicol Appl Pharmacol 207: S367-S374.
19. Schardein JOL, Schwetz BA, Kenel MF. 1985. Species sensitivities and prediction of teratogenic potential. Environ Health Perspect 61: 55-67.
20. Shepard TH, Lemire RJ. 2007. Catalog of teratogenic agents, 12th edition. Baltimore: Johns Hopkins University Press.
21. Tennekes H, Kaufmann W, Dammann M, van Ravenzwaay B. 2004. The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment. Regul Toxicol Pharmacol 40: 293-304.
22. Wise LD, Buschmann J, Feuston MH, Fisher JE, Hew KW, Hoberman AM, Lerman SA, Ooshima Y, Stump DG. 2009. Embryo-fetal developmental toxicity study design for pharmaceuticals. Birth Defects Res B Dev Reprod Toxicol 86: 418-428.
23. Woo DC, Hoar RM. 1972. "Apparent hydronephrosis" as a normal aspect of renal development in late gestation of rats: The effect of methyl salicylate. Teratology 6: 191-196.